|Articles|September 23, 2021
Elligo Health Research Acquires ClinEdge
Advertisement
Elligo Health Research has announced the acquisition of ClinEdge, which also includes GuideStar Research and BTC of New Bedford. The transaction of $135 million was funded through new co-lead investors Morgan Stanley Expansion Capital and Ally Bridge, along with participation from Norwest Venture Partners and existing investors.
Perella Weinberg Partners served as financial advisor and Goodwin Procter LLP served as legal counsel to Elligo. Edgemont Partners served as exclusive financial advisor to ClinEdge.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
3
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
4
ACT Brief: Enterprise Risk Management, Execution Architecture for AI, and Rare Pediatric Regulatory Support
5